| 1602.50 | | Of bovine animals: | | | | |
| 1602.90 | | Other, including preparations of blood of any animal: | | | | |
| 2308.00 | | Vegetable materials and vegetable waste, vegetable residues and byproducts, whether or not in the form of pellets, of a kind used in animal feeding, not elsewhere specified or included: | | | | |
| 2309 | | Preparations of a kind used in animal feeding: | | | | |
| 2309.90.22 | | Animal feeds containing milk or milk derivatives: | | | | |
| 2309.90.60 | 00 | Animal feeds containing egg | kg | 1.9% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 20% |
| 2309.90.70 | 00 | Preparations, with a basis of vitamin B12, for supplementing animal feed | kg | 1.4% | Free (A,AU,BH,CA, CL,E,IL,J,JO,MA, MX,P,SG) | 20% |
| 2403.10.20 | | Prepared for marketing to the ultimate consumer in the identical form and package in which imported | | 32.8￠/kg | Free (A+,AU,BH, CA,CL,D,E,IL,J, MA,MX,P,SG) | $1.21/kg |
| 2403.99.20 | | Prepared for marketing to the ultimate consumer in the identical form and package in which imported | | 24.7￠/kg | Free (A+,AU,BH, CA,CL,D,E,IL,J, MA,MX,P,SG) | $1.21/kg |
| 2508 | | Other clays (not including expanded clays of heading 6806), andalusite, kyanite and sillimanite, whether or not calcined; mullite; chamotte or dinas earths: | | | | |
| 2508.50.00 | 00 | Andalusite, kyanite and sillimanite | t | Free | | Free |
| 2710.19.35 | 00 | Containing not over 10 percent by weight of salts of fatty acids of animal (including marine animal) or vegetable origin | kg | 5.8% | Free (A,AU,BH, CA,CL,IL,J+,JO, MA,MX,P, R,SG) | 20% |
| 2710.99.32 | 00 | Containing not over 10 percent by weight of salts of fatty acids of animal (including marine animal) or vegetable origin | kg | 5.8% | Free (A,AU,BH, CA,CL,IL,J+,JO, MA,MX,P, R,SG) | 20% |
| 2915.90.10 | | Fatty acids of animal or vegetable origin | | 5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 20% |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.23.10 | | Obtained directly or indirectly from animal or vegetable materials | | Free | | 25% |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 50 | Medicaments primarily affecting the digestive system: | | | | |
